Vertex Pharmaceuticals Incorporated (BCBA:VRTX)
Argentina flag Argentina · Delayed Price · Currency is ARS
7,190.00
+155.00 (2.20%)
At close: Feb 27, 2026

Vertex Pharmaceuticals Statistics

Total Valuation

BCBA:VRTX has a market cap or net worth of ARS 178.08 trillion. The enterprise value is 163.57 trillion.

Market Cap 178.08T
Enterprise Value 163.57T

Important Dates

The next estimated earnings date is Monday, May 4, 2026.

Earnings Date May 4, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.04%
Shares Change (QoQ) -0.58%
Owned by Insiders (%) 0.21%
Owned by Institutions (%) 94.80%
Float 253.26M

Valuation Ratios

The trailing PE ratio is 31.04 and the forward PE ratio is 25.81.

PE Ratio 31.04
Forward PE 25.81
PS Ratio 10.22
PB Ratio 6.57
P/TBV Ratio 7.15
P/FCF Ratio 38.42
P/OCF Ratio 33.79
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.68, with an EV/FCF ratio of 35.29.

EV / Earnings 28.51
EV / Sales 9.66
EV / EBITDA 22.68
EV / EBIT 24.73
EV / FCF 35.29

Financial Position

The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.11.

Current Ratio 2.90
Quick Ratio 2.24
Debt / Equity 0.11
Debt / EBITDA 0.40
Debt / FCF 0.64
Interest Coverage 352.44

Financial Efficiency

Return on equity (ROE) is 22.54% and return on invested capital (ROIC) is 29.61%.

Return on Equity (ROE) 22.54%
Return on Assets (ROA) 12.16%
Return on Invested Capital (ROIC) 29.61%
Return on Capital Employed (ROCE) 21.52%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 2.72B
Profits Per Employee 896.51M
Employee Count 6,400
Asset Turnover 0.50
Inventory Turnover 3.85

Taxes

In the past 12 months, BCBA:VRTX has paid 1.00 trillion in taxes.

Income Tax 1.00T
Effective Tax Rate 14.86%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 6,921.10
200-Day Moving Average n/a
Relative Strength Index (RSI) 57.89
Average Volume (20 Days) 1,508

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.12

Income Statement

In the last 12 months, BCBA:VRTX had revenue of ARS 17.42 trillion and earned 5.74 trillion in profits. Earnings per share was 22,235.45.

Revenue 17.42T
Gross Profit 9.35T
Operating Income 6.80T
Pretax Income 6.74T
Net Income 5.74T
EBITDA 7.06T
EBIT 6.80T
Earnings Per Share (EPS) 22,235.45

Balance Sheet

The company has 9.59 trillion in cash and 2.96 trillion in debt, giving a net cash position of 14.93 trillion.

Cash & Cash Equivalents 9.59T
Total Debt 2.96T
Net Cash 14.93T
Net Cash Per Share n/a
Equity (Book Value) 27.09T
Book Value Per Share 106,663.30
Working Capital 10.65T

Cash Flow

In the last 12 months, operating cash flow was 5.27 trillion and capital expenditures -635.13 billion, giving a free cash flow of 4.64 trillion.

Operating Cash Flow 5.27T
Capital Expenditures -635.13B
Free Cash Flow 4.64T
FCF Per Share n/a

Margins

Gross margin is 53.67%, with operating and profit margins of 39.06% and 32.94%.

Gross Margin 53.67%
Operating Margin 39.06%
Pretax Margin 38.69%
Profit Margin 32.94%
EBITDA Margin 40.55%
EBIT Margin 39.06%
FCF Margin 26.61%

Dividends & Yields

BCBA:VRTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.04%
Shareholder Yield -0.04%
Earnings Yield 3.22%
FCF Yield 2.60%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BCBA:VRTX has an Altman Z-Score of 11.93 and a Piotroski F-Score of 6.

Altman Z-Score 11.93
Piotroski F-Score 6